Novo Nordisk has landed an approval from the US Food and Drug Administration (FDA) for a high dose version of its best-selling weight loss drug, Wegovy (semaglutide), as patents covering the therapy's market exclusivity edge closer to expiry in certain locations
However, most patients benefit from dose increases after four weeks, as the body develops tolerance to appetite-suppressing effects
According to Allo Health, every 1 in 2 patients has ED, which is based on our internal clinical data of more than 2.5 Lakh patients who come to our clinic and established options like Cialis for ED remain first-line
doi: 10.1111/j.1365-2125.2012.04214.x 106 SmitsMMTonneijckLMuskietMHAHoekstraTKramerMHHDiamantMet al
Hearing real patient stories and learning about evidence-backed procedures can clarify whether excisional surgery, liposuction, or a combination best addresses your goals
Some people stop early due to side effects, cost, or life changes